Michel Israel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michel Israel has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
M. Ivanova
National Centre of Public Health and Analysis, Sofia, Bulgaria
3 shared publicationsHristina Petkova
2 shared publications- Mihaela Ivanova
National Centre of Public Health and Analyses, 1431 Sofia, Bulgaria
2 shared publications - Mihaela Ivanova
Department of Milk and Dairy Technology, University of Food Technologies, 4002 Plovdiv, Bulgaria
2 shared publications P. Ivanova
National Centre of Public Health and Analyses, Sofia, Bulgaria
2 shared publications- Tsvetelina Shalamanova
National Center of Public Health and Analyses, Sofia, Bulgaria
2 shared publications
Latest Publications
- Open Access
- 9 August 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (16) , 6552
Occupational Exposure to Electromagnetic Fields—Different from General Public Exposure and Laboratory Studies
The designs of in vivo, in vitro and in silico studies do not adequately reflect the characteristics of long-term occupational EMF exposure; the higher exposure levels permitted for employees are nevertheless extrapolated on this basis. Epidemiological studies consider occupational exposure only in a very general way, if at all. There is a lack of detailed descriptive data on long-term occupational exposure over the duration of the working life. Most studies reflect exposure characteristics of the general population, exposures which are long-term, but at a comparably low level. Occupational exposure is often intermittent with high peak power followed by periods with no exposure. Furthermore, the EU EMF-Directive 2013/35/EU states a demand for occupational health surveillance, the outcome of which would be of great help to epidemiologists studying the health effects of EMF exposure. This paper thus aims to outline and specify differences between public and occupational exposure and to increase the understanding of specific aspects of occupational exposure which are important for long-term health considerations. This could lead to a future protection concept against possible hazards based on adequate descriptions of long-term exposures and also include supplementary descriptive features such as a “reset time” of biological systems and accurate dose quantities.
- 9 August 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (16) , 6552
Open AccessOccupational Exposure to Electromagnetic Fields—Different from General Public Exposure and Laboratory Studies
The designs of in vivo, in vitro and in silico studies do not adequately reflect the characteristics of long-term occupational EMF exposure; the higher exposure levels permitted for employees are nevertheless extrapolated on this basis. Epidemiological studies consider occupational exposure only in a very general way, if at all. There is a lack of detailed descriptive data on long-term occupational exposure over the duration of the working life. Most studies reflect exposure characteristics of the general population, exposures which are long-term, but at a comparably low level. Occupational exposure is often intermittent with high peak power followed by periods with no exposure. Furthermore, the EU EMF-Directive 2013/35/EU states a demand for occupational health surveillance, the outcome of which would be of great help to epidemiologists studying the health effects of EMF exposure. This paper thus aims to outline and specify differences between public and occupational exposure and to increase the understanding of specific aspects of occupational exposure which are important for long-term health considerations. This could lead to a future protection concept against possible hazards based on adequate descriptions of long-term exposures and also include supplementary descriptive features such as a “reset time” of biological systems and accurate dose quantities.
- Open Access
- 1 January 2022
- Published by RAD Centre
Problems with general public and workers protection on using optical radiation sources for cosmetic purposes
- 1 January 2022
- Published by RAD Centre
Open AccessProblems with general public and workers protection on using optical radiation sources for cosmetic purposes
- Open Access
- 1 January 2022
- Published by RAD Centre
Evaluation of the electromagnetic field and safety zones of existing base stations upgraded with 5G Massive MIMO antennas
- 1 January 2022
- Published by RAD Centre
Open AccessEvaluation of the electromagnetic field and safety zones of existing base stations upgraded with 5G Massive MIMO antennas
- Open Access
- 1 January 2021
- Published by Sievert Association
Patient and personnel health and safety in Magnetic Resonance Imaging Facility
- 1 January 2021
- Published by Sievert Association
Open AccessPatient and personnel health and safety in Magnetic Resonance Imaging Facility
- Open Access
- 31 January 2015
- Published by Science Publishing Group in Science Journal of Public Health
- Vol. 3 (1) , 101-106
Exposure Assessment of Magnetic Field in Dwellings with Built-in Transformers in Bulgaria
An exposure assessment study was performed within a sample of apartment buildings with built-in transformer rooms located throughout the Sofia city. This study was a part of the International project TRANSEXPO which goal was to find the epidemiologic association between extremely low frequency magnetic fields (ELF-MF) and childhood leukemia. The exposure assessment part was directed to estimation of magnetic field exposures in residences that are both near to and distant from the transformer room, based upon their location relative to the transformer station. Measurements of 50 Hz magnetic field (MF) were performed in 65 apartments, 21 buildings, with built-in transformer stations. In each building, measurements were made in the following types of apartments: 1. apartments that have rooms directly above and next to the transformer; 2. apartments selected on the same floor as the one directly above and next to the transformer; 3. apartments on the upper floors randomly selected among all the other apartments of the building; The measurement results show clear difference among the magnetic field values measured of the three categories of apartments, respectively 0,4 µT for the “exposed” apartments 0,23 µT on the same floor, and 0,1 µT on other floors. These results confirm that classification of magnetic field exposure based on apartment location is possible with specificity 0,91 and sensitivity 0,95 for cut-off point 0,4 µT. Values of 0,4 µT and above were measured in 18 out of 19 apartments that have rooms directly above and next to the transformer. The exposure assessment in the buildings with built-in transformer station shows that the apartments can be reliably categorized as an exposed, low exposed or unexposed based on their location to the transformer stations.
- 31 January 2015
- Published by Science Publishing Group in Science Journal of Public Health
- Vol. 3 (1) , 101-106
Open AccessExposure Assessment of Magnetic Field in Dwellings with Built-in Transformers in Bulgaria
An exposure assessment study was performed within a sample of apartment buildings with built-in transformer rooms located throughout the Sofia city. This study was a part of the International project TRANSEXPO which goal was to find the epidemiologic association between extremely low frequency magnetic fields (ELF-MF) and childhood leukemia. The exposure assessment part was directed to estimation of magnetic field exposures in residences that are both near to and distant from the transformer room, based upon their location relative to the transformer station. Measurements of 50 Hz magnetic field (MF) were performed in 65 apartments, 21 buildings, with built-in transformer stations. In each building, measurements were made in the following types of apartments: 1. apartments that have rooms directly above and next to the transformer; 2. apartments selected on the same floor as the one directly above and next to the transformer; 3. apartments on the upper floors randomly selected among all the other apartments of the building; The measurement results show clear difference among the magnetic field values measured of the three categories of apartments, respectively 0,4 µT for the “exposed” apartments 0,23 µT on the same floor, and 0,1 µT on other floors. These results confirm that classification of magnetic field exposure based on apartment location is possible with specificity 0,91 and sensitivity 0,95 for cut-off point 0,4 µT. Values of 0,4 µT and above were measured in 18 out of 19 apartments that have rooms directly above and next to the transformer. The exposure assessment in the buildings with built-in transformer station shows that the apartments can be reliably categorized as an exposed, low exposed or unexposed based on their location to the transformer stations.
- 15 May 2013
- Published by Taylor & Francis in Electromagnetic Biology and Medicine
- Vol. 32 (2) , 145-154
Electromagnetic field occupational exposure: Non-thermal vs. thermal effects
There are a variety of definitions for "non-thermal effects" included in different international standards. They start by the simple description that they are "effects of electromagnetic energy on a body that are not heat-related effects", passing through the very general definition related to low-level effects: "biological effects ascribed to exposure to low-level electric, magnetic and electromagnetic fields, i.e. at or below the corresponding dosimetric reference levels in the frequency range covered in this standard (0 Hz-300 GHz)", and going to the concrete definition of "the stimulation of muscles, nerves, or sensory organs, vertigo or phosfenes". Here, we discuss what kind of effect does the non-thermal one has on human body and give data of measurements in different occupations with low-frequency sources of electromagnetic field such as electric power distribution systems, transformers, MRI systems and : video display units (VDUs), whereas thermal effects should not be expected. In some of these workplaces, values above the exposure limits could be found, nevertheless that they are in the term "non-thermal effects" on human body. Examples are workplaces in MRI, also in some power plants. Here, we will not comment on non-thermal effects as a result of RF or microwave exposure because there are not proven evidence about the existance of such effects and mechanisms for them are not clear.
- 15 May 2013
- Published by Taylor & Francis in Electromagnetic Biology and Medicine
- Vol. 32 (2) , 145-154
Electromagnetic field occupational exposure: Non-thermal vs. thermal effects
There are a variety of definitions for "non-thermal effects" included in different international standards. They start by the simple description that they are "effects of electromagnetic energy on a body that are not heat-related effects", passing through the very general definition related to low-level effects: "biological effects ascribed to exposure to low-level electric, magnetic and electromagnetic fields, i.e. at or below the corresponding dosimetric reference levels in the frequency range covered in this standard (0 Hz-300 GHz)", and going to the concrete definition of "the stimulation of muscles, nerves, or sensory organs, vertigo or phosfenes". Here, we discuss what kind of effect does the non-thermal one has on human body and give data of measurements in different occupations with low-frequency sources of electromagnetic field such as electric power distribution systems, transformers, MRI systems and : video display units (VDUs), whereas thermal effects should not be expected. In some of these workplaces, values above the exposure limits could be found, nevertheless that they are in the term "non-thermal effects" on human body. Examples are workplaces in MRI, also in some power plants. Here, we will not comment on non-thermal effects as a result of RF or microwave exposure because there are not proven evidence about the existance of such effects and mechanisms for them are not clear.
- 18 February 2011
- Published by Springer Nature in Environmentalist
- Vol. 31 (2) , 161-168
Electromagnetic fields and other physical factors around wind power generators (pilot study)
- 18 February 2011
- Published by Springer Nature in Environmentalist
- Vol. 31 (2) , 161-168
Electromagnetic fields and other physical factors around wind power generators (pilot study)
- 18 January 2011
- Published by Springer Nature in Environmentalist
- Vol. 31 (2) , 121-129
Criticism of the philosophy for development of standards for non-ionizing radiation
- 18 January 2011
- Published by Springer Nature in Environmentalist
- Vol. 31 (2) , 121-129
Criticism of the philosophy for development of standards for non-ionizing radiation
- 23 July 2004
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 129 (31/32) , 1669-1673
Epidemiologie medikamentöser Parasuizide
Hintergrund und Fragestellung: Repräsentative Daten zur Epidemiologie von Parasuiziden existieren für Deutschland nur in beschränktem Umfang. In der vorliegenden Arbeit sollten Häufigkeit von parasuizidalen Arzneimittelintoxikationen, Alters- und Geschlechtsverteilung sowie Art und Herkunft der zum Parasuizid verwendeten Arzneimittel erfasst werden. Außerdem wurden Arzneimittelkenntnisse der Patienten und mögliche unerwünschte Wirkungen einer vorbestehenden Medikation analysiert. Patienten und Methodik: Über einen Zeitraum von 2 Jahren (Januar 1998-Dezember 1999) wurden die Daten von 155 Patienten (41 männlich, 114 weiblich, Durchschnittsalter 40,5 Jahre) mit parasuizidalen Arzneimittelintoxikationen am Universitätsklinikum Dresden in einer retrospektiven Beobachtungsstudie erfasst. Ergebnisse: 74 % der untersuchten Parasuizidenten waren Frauen. In der Mehrzahl dieser Arzneimittelintoxikationen wurden Sedativa und Hypnotika verwendet (44 %), gefolgt von Analgetika (18 %) und Antidepressiva (12 %). Benzodiazepine und Benzodiazepinrezeptoragonisten standen an erster Stelle der eingenommenen Substanzgruppen (32 %). Die überwiegende Anzahl (80 %) der zum Parasuizid eingesetzten Arzneimittel war ärztlich verordnet worden. Etwa die Hälfte aller Parasuizidenten hatten eingehende Kenntnisse über die verwendeten Arzneimittel. Bei 43 (47 %) von insgesamt 92 Patienten mit Langzeitmedikation bestand der Verdacht auf eine unerwünschte Arzneimittelwirkung als möglicher Auslöser des Parasuizids. Folgerung: Die vorliegenden Daten unterstreichen die Bedeutung medikamentöser Parasuizide im Hinblick auf die Häufigkeit ihres Auftretens, konsekutiv erforderlicher Krankenhausaufenthalte, der Notwendigkeit intensivmedizinischer Betreuung und möglicher Rezidive. Vor dem Hintergrund der Anwendung überwiegend ärztlich verordneter Arzneistoffe sollte Suizidalität vor jeder Verschreibung kritisch hinterfragt werden. Background and objective: Little representative data of the epidemiology of attempted suicide exists in Germany. In this study the frequency of parasuicidal drug intoxication, the distribution of age and gender, as well as the kind and origin of used drugs were evaluated. Furthermore the knowledge about used drugs and possible adverse effects of a previously given medication were analysed. Patients and methods: Over a period of 2 years (January 1998-December 1999) 155 patients (41males, 114 females, average age 40.5 years) with drug intoxication by attempted suicide were recruited at the University Hospital of Dresden, Germany, for further retrospective analysis. Results: 74 % of these patients were women. Sedatives and hypnotics were most frequently used for parasuicide (44 %), followed by analgesics (18 %) and antidepressants (12 %). Benzodiazepines and benzodiazepine-agonists were the most commonly used drugs (32 %). Moreover, 80 % of all drugs used had been prescribed by physicians. Approximately half of the patients were well-informed about drugs taken. In 43 (47 %) of 92 patients with long-term medication an adverse effect was considered as a possible cause of the attempted suicide. Conclusion: Our data underline the importance of attempted suicide in view of the frequency of their use, the need of hospitalization, the required intensive care and possible relapses. Because the majority of drugs used were prescribed by physicians, before giving any medication to their possible suicidal use should be considered. 1 Das Projekt wurde gefördert durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; Fo 2.1-68502-201) und das Bundesministerium für Bildung und Forschung (BMBF 01EG0201). Teile der Ergebnisse wurden auf dem EUPHA Kongress 2002 in Dresden, Deutschland, vorgestellt und als Abstract in der Zeitschrift Eur J Public Health 2002; 12:123 veröffentlicht.
- 23 July 2004
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 129 (31/32) , 1669-1673
Epidemiologie medikamentöser Parasuizide
Hintergrund und Fragestellung: Repräsentative Daten zur Epidemiologie von Parasuiziden existieren für Deutschland nur in beschränktem Umfang. In der vorliegenden Arbeit sollten Häufigkeit von parasuizidalen Arzneimittelintoxikationen, Alters- und Geschlechtsverteilung sowie Art und Herkunft der zum Parasuizid verwendeten Arzneimittel erfasst werden. Außerdem wurden Arzneimittelkenntnisse der Patienten und mögliche unerwünschte Wirkungen einer vorbestehenden Medikation analysiert. Patienten und Methodik: Über einen Zeitraum von 2 Jahren (Januar 1998-Dezember 1999) wurden die Daten von 155 Patienten (41 männlich, 114 weiblich, Durchschnittsalter 40,5 Jahre) mit parasuizidalen Arzneimittelintoxikationen am Universitätsklinikum Dresden in einer retrospektiven Beobachtungsstudie erfasst. Ergebnisse: 74 % der untersuchten Parasuizidenten waren Frauen. In der Mehrzahl dieser Arzneimittelintoxikationen wurden Sedativa und Hypnotika verwendet (44 %), gefolgt von Analgetika (18 %) und Antidepressiva (12 %). Benzodiazepine und Benzodiazepinrezeptoragonisten standen an erster Stelle der eingenommenen Substanzgruppen (32 %). Die überwiegende Anzahl (80 %) der zum Parasuizid eingesetzten Arzneimittel war ärztlich verordnet worden. Etwa die Hälfte aller Parasuizidenten hatten eingehende Kenntnisse über die verwendeten Arzneimittel. Bei 43 (47 %) von insgesamt 92 Patienten mit Langzeitmedikation bestand der Verdacht auf eine unerwünschte Arzneimittelwirkung als möglicher Auslöser des Parasuizids. Folgerung: Die vorliegenden Daten unterstreichen die Bedeutung medikamentöser Parasuizide im Hinblick auf die Häufigkeit ihres Auftretens, konsekutiv erforderlicher Krankenhausaufenthalte, der Notwendigkeit intensivmedizinischer Betreuung und möglicher Rezidive. Vor dem Hintergrund der Anwendung überwiegend ärztlich verordneter Arzneistoffe sollte Suizidalität vor jeder Verschreibung kritisch hinterfragt werden. Background and objective: Little representative data of the epidemiology of attempted suicide exists in Germany. In this study the frequency of parasuicidal drug intoxication, the distribution of age and gender, as well as the kind and origin of used drugs were evaluated. Furthermore the knowledge about used drugs and possible adverse effects of a previously given medication were analysed. Patients and methods: Over a period of 2 years (January 1998-December 1999) 155 patients (41males, 114 females, average age 40.5 years) with drug intoxication by attempted suicide were recruited at the University Hospital of Dresden, Germany, for further retrospective analysis. Results: 74 % of these patients were women. Sedatives and hypnotics were most frequently used for parasuicide (44 %), followed by analgesics (18 %) and antidepressants (12 %). Benzodiazepines and benzodiazepine-agonists were the most commonly used drugs (32 %). Moreover, 80 % of all drugs used had been prescribed by physicians. Approximately half of the patients were well-informed about drugs taken. In 43 (47 %) of 92 patients with long-term medication an adverse effect was considered as a possible cause of the attempted suicide. Conclusion: Our data underline the importance of attempted suicide in view of the frequency of their use, the need of hospitalization, the required intensive care and possible relapses. Because the majority of drugs used were prescribed by physicians, before giving any medication to their possible suicidal use should be considered. 1 Das Projekt wurde gefördert durch das Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; Fo 2.1-68502-201) und das Bundesministerium für Bildung und Forschung (BMBF 01EG0201). Teile der Ergebnisse wurden auf dem EUPHA Kongress 2002 in Dresden, Deutschland, vorgestellt und als Abstract in der Zeitschrift Eur J Public Health 2002; 12:123 veröffentlicht.